Avenue Therapeutics Statistics
Total Valuation
ATXI has a market cap or net worth of 787,740. The enterprise value is -2.75 million.
| Market Cap | 787,740 |
| Enterprise Value | -2.75M |
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ATXI has 3.15 million shares outstanding. The number of shares has increased by 817.14% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 3.15M |
| Shares Change (YoY) | +817.14% |
| Shares Change (QoQ) | +18.44% |
| Owned by Insiders (%) | 0.72% |
| Owned by Institutions (%) | 9.57% |
| Float | 2.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.42 |
| P/TBV Ratio | 0.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.24 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.27
| Current Ratio | 3.27 |
| Quick Ratio | 3.18 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -931.95% and return on invested capital (ROIC) is -561.90%.
| Return on Equity (ROE) | -931.95% |
| Return on Assets (ROA) | -311.89% |
| Return on Invested Capital (ROIC) | -561.90% |
| Return on Capital Employed (ROCE) | -607.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -5.83M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.51% in the last 52 weeks. The beta is 0.10, so ATXI's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -97.51% |
| 50-Day Moving Average | 0.68 |
| 200-Day Moving Average | 1.87 |
| Relative Strength Index (RSI) | 23.26 |
| Average Volume (20 Days) | 12,774 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.19 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.28M |
| Pretax Income | -11.70M |
| Net Income | -11.65M |
| EBITDA | n/a |
| EBIT | -11.28M |
| Earnings Per Share (EPS) | -9.00 |
Balance Sheet
The company has 2.59 million in cash and n/a in debt, giving a net cash position of 2.59 million or 0.82 per share.
| Cash & Cash Equivalents | 2.59M |
| Total Debt | n/a |
| Net Cash | 2.59M |
| Net Cash Per Share | 0.82 |
| Equity (Book Value) | 1.86M |
| Book Value Per Share | 1.33 |
| Working Capital | 1.86M |
Cash Flow
| Operating Cash Flow | -9.03M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATXI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -817.14% |
| Shareholder Yield | -817.14% |
| Earnings Yield | -1,479.17% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on April 26, 2024. It was a reverse split with a ratio of 0.0133333.
| Last Split Date | Apr 26, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0133333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |